CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Amie Hayley

OPENALEX: A5072212376↗ORCID: 0000-0002-4470-4718↗

Affiliations

Organizations

Austin Healthauthorship · AU Austin Hospitalauthorship · AU Institute for Breathing and Sleepauthorship · AU International Council for Research and Innovation in Building and Constructionauthorship · NL Swinburne University of Technologyauthorship · AU

Public evidence

5 connected articles

Same-Day Sedative and Night-Time Sleep Effects Following Combined Cannabinoid Formulations: A Randomised-Controlled Trial.2025 · Europe PMC The effect of nightly use of 150 mg cannabidiol on daytime neurocognitive performance in primary insomnia: a randomized controlled pilot trial.2025 · Europe PMC A semi-naturalistic open-label study examining the effect of prescribed medical cannabis use on simulated driving performance.2024 · Europe PMC Effect of CannEpil<sup>®</sup> on simulated driving performance and co-monitoring of ocular activity: A randomised controlled trial.2023 · Europe PMC A Semi-Naturalistic, Open-Label Trial Examining the Effect of Prescribed Medical Cannabis on Neurocognitive Performance.2023 · PubMed Central Open Access

Registered research

Connected studies

Dose Ranging Clinical Study to Evaluate the Effects of Oral Delta-9-tetrahydrocannabinol (Δ9-THC) With and Without Alcohol on Perception and Driving Performance in Healthy Adultsnct07176208

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 09/09/2026.

Amie Hayley - Medical Cannabis Research Engine